Insulin Resistance in Athletes: How You Can Look Fit but Still Be Metabolically Unwell

there is also insulin resistance in athletes

Insulin resistance in athletes and active individuals is far more common than standard clinical assumptions suggest.

Fitness and metabolic health are not the same thing. They can coexist — but they do not automatically. And the assumption that they do is one of the most consequential misconceptions in modern health culture.

An individual can train regularly, maintain a lean physique, perform well in the gym or on the field, and still have chronically elevated insulin, a dysregulated gut-liver axis, and a metabolic trajectory pointing toward insulin resistance. Their body composition looks fine. Their performance metrics look fine. Their standard blood panel — glucose, HbA1c, total cholesterol — looks fine. And yet the hormonal and inflammatory picture underneath tells a different story.

This post is not about elite athletes with rare physiological edge cases. It is about the much larger and far less discussed population of regularly active people — gym-goers, recreational runners, crossfit participants, cyclists — who have been told, implicitly or explicitly, that their exercise habit is protecting their metabolic health. In many cases it is not. And understanding why requires separating what exercise does from what it cannot compensate for.

What you will learn: Why physical fitness does not guarantee metabolic health | The specific mechanisms through which active individuals develop insulin resistance despite regular training | Why the gut-liver axis is the most underestimated driver in this population | What the dietary patterns look like that undermine exercise-derived metabolic benefit | How to identify hidden insulin resistance in an active individual and what markers to use

Clinical Perspective: What I See in Practice

I want to be direct about my clinical experience with this population, because honesty in clinical writing matters more than a compelling narrative that overstates what has actually been observed.

The patients I see most frequently in this category are not currently athletic. They are formerly athletic — people who trained seriously for years, built genuine physical fitness, and then found that work demands, family circumstances, or life transitions made that level of activity unsustainable. They did not stop moving entirely. But their training volume dropped significantly. Their dietary habits, however — built around the caloric and carbohydrate demands of active training — did not change at the same pace. The high carbohydrate intake that was partially justified by training volume continued into a period of substantially lower activity. The metabolic consequences arrived gradually and were initially invisible to standard screening.

They come to me when the picture has become impossible to ignore — rising waist circumference, fatigue that their previous fitness level would never have produced, lipid markers drifting in the wrong direction, and a general sense that something has shifted metabolically that training alone is not fixing.

The highly active patients I do see — currently training, good physical condition by any external standard — present a different and in some ways more instructive challenge. In almost none of these cases do I have a fasting insulin result when they arrive. Their GPs have not ordered it. So I work from what I have: the TG/HDL ratio, HbA1c, liver enzymes, waist circumference, and a detailed 75-minute consultation that goes through their diet and lifestyle in granular detail.

What I find consistently in this group is not what they expect me to find. They expect me to talk about training load, recovery, or macro ratios. What I actually find is the gut-liver axis — disrupted by the very products the fitness industry has normalized as healthy fuel. Protein bars loaded with seed oils and high-fructose corn syrup. Gym drinks with industrial sweeteners and refined carbohydrate blends. Post-workout snacks from the supermarket health aisle with ingredient lists that read like a food chemistry textbook. These products are causing microbiome dysbiosis. The dysbiosis increases intestinal permeability. Lipopolysaccharide from gram-negative bacteria crosses the compromised barrier, enters the portal circulation, and reaches the liver — where it activates TLR4 on Kupffer cells, triggers NF-κB-mediated inflammation, and directly impairs hepatic insulin signaling.

The carbohydrate load itself is not always the primary culprit in this population. The gut-liver axis disruption driven by ultra-processed sports nutrition products is, in my clinical observation, the most underestimated and most consistently overlooked driver of insulin resistance in active individuals. It does not show up on any standard panel. It does not produce dramatic symptoms. And it is being actively promoted by an industry that has convinced physically active people that these products are aligned with their health goals.

The other pattern I observe consistently is what I think of as the compensatory trap. Active individuals — particularly those training in the evening — allow themselves dietary choices they would otherwise avoid on the basis that the training earns them. Late dinner after returning from the gym at 10 or 11pm. Poor sleep because the training-induced cortisol and adrenaline take hours to subside. Cravings the following day driven by the combination of poor sleep, elevated cortisol, and the blood sugar dysregulation that follows a late high-carbohydrate meal eaten close to sleep. The training session is real. The metabolic benefit is being systematically undermined by everything surrounding it.

Why Exercise Alone Cannot Guarantee Metabolic Health

Exercise improves insulin sensitivity through well-characterized mechanisms — primarily by expanding skeletal muscle’s capacity for insulin-independent glucose uptake via GLUT4 translocation, improving mitochondrial density and oxidative capacity, and reducing visceral adiposity over time. These are genuine and significant metabolic benefits.

But exercise operates on a specific and limited set of metabolic variables. It does not neutralize chronic gut-derived inflammation. It does not correct a dysregulated gut-liver axis. It does not compensate for the hepatic insulin resistance produced by LPS-driven TLR4 activation. And it does not override the hormonal consequences of chronically poor sleep, sustained cortisol elevation, or a dietary pattern built around ultra-processed products regardless of how those products are marketed.

The metabolic benefits of exercise are real and well-evidenced. They are also conditional. They require a dietary and lifestyle environment that does not simultaneously generate the upstream drivers that exercise is partially offsetting. When those drivers are strong enough — and in many active individuals they are — the net metabolic picture can remain compromised despite genuine training effort.

This is the core of what active patients with hidden insulin resistance find so difficult to accept: the training is not failing. The training is working. It is simply being outpaced by factors that training cannot address.

The Dietary Pattern That Undermines Exercise

The nutritional profile of metabolically unwell active individuals follows a recognizable pattern that diverges significantly from what the fitness industry communicates as healthy fueling.

Ultra-processed sports nutrition products are the most consistently problematic element. Protein bars, pre-workout formulations, recovery drinks, and supermarket health snacks marketed to active individuals frequently contain industrial seed oils high in omega-6 linoleic acid, high-fructose corn syrup or other refined sweeteners, emulsifiers that directly disrupt the intestinal mucus layer, and refined carbohydrate matrices that produce rapid glucose and insulin spikes regardless of how they are branded.

The gut-liver axis consequence of regular consumption of these products is not theoretical. Industrial seed oils promote a pro-inflammatory omega-6 to omega-3 ratio that directly impairs gut barrier integrity. Emulsifiers including polysorbate 80 and carboxymethylcellulose have been demonstrated to alter the gut microbiome composition and increase intestinal permeability in experimental models. HFCS drives hepatic de novo lipogenesis independently of training-induced glucose disposal. The combination — consumed regularly as part of a fitness-oriented dietary pattern — creates chronic low-grade metabolic endotoxemia that exercise does not resolve.

Frequent eating in the name of fueling is the second major pattern. The sports nutrition paradigm of eating every two to three hours — protein with every meal, pre-workout fuel, intra-workout nutrition, post-workout recovery window — maintains insulin in a near-continuously elevated state that prevents the low-insulin fasting periods required for receptor sensitivity recovery. An individual who trains for one hour but eats across a 16-hour window with six feeding occasions has an insulin profile that no amount of training can fully compensate for.

Compensatory eating after evening training compounds this pattern with a specific circadian dimension. Late-night eating — regardless of macronutrient composition — conflicts with the natural decline in insulin sensitivity that occurs in the evening as part of the circadian metabolic rhythm. A high-carbohydrate meal consumed at 10pm after an evening training session produces a postprandial glucose and insulin response that is significantly larger than the same meal consumed at noon — and it occurs at exactly the moment when cortisol from the training session is still elevated, sleep onset is delayed, and the hormonal environment is least equipped to manage the metabolic load efficiently.

Poor sleep as a consequence of training timing closes the loop. Evening training raises core body temperature and elevates sympathetic nervous system activity — both of which delay sleep onset and reduce slow-wave sleep duration. Chronically shortened or fragmented sleep elevates fasting cortisol, increases insulin resistance measurably within days, and drives appetite-stimulating pathways the following day that sustain the compensatory eating pattern. The training session that was supposed to improve metabolic health has, through its timing and its downstream effects on sleep and appetite, contributed to the hormonal environment it was meant to correct.

The Gut-Liver Axis: The Most Underestimated Driver

In active individuals with hidden insulin resistance, the gut-liver axis is the mechanism that most consistently explains the disconnect between their apparent fitness and their actual metabolic state. It is also the mechanism most consistently ignored by sports medicine, conventional dietetics, and the fitness industry.

The intestinal barrier — when functioning correctly — acts as a selective interface between the gut microbiome and the portal circulation. Tight junction proteins between enterocytes prevent bacterial components from crossing into the bloodstream. When this barrier is compromised — by ultra-processed food components, seed oils, emulsifiers, HFCS, chronic stress, and sleep deprivation — lipopolysaccharide (LPS) from gram-negative bacteria translocates across the intestinal wall and enters the portal vein.

The liver receives this LPS load first. Kupffer cells — the liver’s resident macrophages — express TLR4 receptors that bind LPS and activate the NF-κB inflammatory cascade. This produces hepatic TNF-alpha and IL-6 secretion, oxidative stress, and direct impairment of insulin receptor signaling through serine phosphorylation of IRS-1. The result is hepatic insulin resistance — the liver continues autonomous glucose production despite elevated insulin — which drives compensatory hyperinsulinemia and the full downstream metabolic consequence cascade.

This process operates entirely independently of training volume, body composition, or cardiovascular fitness. A person can be genuinely aerobically fit, maintain a healthy body weight, and have a gut-liver axis that is generating chronic hepatic insulin resistance through daily LPS translocation driven by their sports nutrition product consumption. Their training is improving their peripheral insulin sensitivity. Their diet is simultaneously impairing their hepatic insulin signaling. The net result is a metabolic picture that looks confusing until the gut-liver axis is recognized as the missing variable.

The gut-liver axis is discussed in detail in a dedicated post on this site. In the context of athletic insulin resistance, it is not a secondary consideration — it is frequently the primary mechanism.

How to Identify Hidden Insulin Resistance in Athletes and Active Individual

The markers that reveal insulin resistance in active individuals are the same ones that reveal it in sedentary individuals — but they are even less likely to be ordered, because the clinical assumption that active people are metabolically protected runs deep in conventional medicine.

Fasting insulin remains the most direct and informative marker — but as noted, it is almost never included in standard panels and must be specifically requested. In active individuals with hidden insulin resistance, fasting insulin in the 10–18 µIU/mL range is common — below the conventional alarm threshold, above the functional optimal of 5 µIU/mL, and entirely consistent with the compensatory hyperinsulinemia that exercise is partially but not fully offsetting.

Triglyceride-to-HDL ratio is the most practically accessible proxy when fasting insulin is unavailable. A TG/HDL ratio above 2.0 (mg/dL) in an active individual who appears metabolically healthy is a clinically significant signal that the insulin-lipid axis is under strain despite the fitness appearance.

HbA1c in the upper normal range — 5.4–5.6% — in an active individual warrants attention rather than reassurance. Combined with elevated TG/HDL and central adiposity, it indicates that compensatory insulin secretion is becoming less efficient at managing postprandial glucose loads despite training-enhanced peripheral disposal.

Waist circumference and waist-to-height ratio — even in lean, muscular individuals — can reveal visceral adiposity that total body weight and BMI do not capture. A waist-to-height ratio above 0.5 in an otherwise fit individual is a meaningful clinical signal regardless of muscle mass or training history.

ALT and GGT — liver enzymes trending toward the upper end of the conventional normal range reflect the hepatic stress from portal LPS exposure and FFA spillover that the gut-liver axis mechanism produces. In active individuals consuming ultra-processed sports nutrition products regularly, mildly elevated ALT or GGT is a specific indicator of gut-liver axis disruption rather than alcohol or medication effects.

Detailed dietary history — 75 minutes of structured consultation reviewing product labels, eating timing, training schedule, sleep patterns, and stress context — frequently reveals the specific drivers that no blood marker directly captures. The gut-liver axis disruption described above is not visible in any standard panel. It becomes visible through the dietary history.

What Needs to Change: The Intervention Priority for This Population

For active individuals with hidden insulin resistance, the intervention hierarchy is different from the standard metabolic patient because the training infrastructure is already in place. The priority is not to add exercise — it is to stop the dietary and lifestyle patterns that are undermining the exercise that is already happening.

Remove ultra-processed sports nutrition products first. Protein bars, gym drinks, recovery shakes, and supermarket health snacks containing industrial seed oils, HFCS, emulsifiers, or refined carbohydrate matrices should be eliminated before any other dietary change. These products are the primary gut-liver axis disruptors in this population and their removal has an outsized effect relative to their caloric contribution.

Shift training timing where possible. Evening training that consistently produces late eating, delayed sleep onset, and fragmented sleep should be moved earlier in the day where lifestyle permits. The circadian metabolic benefit of earlier training — better insulin sensitivity, better sleep, lower overnight cortisol — compounds over weeks and months.

Extend the overnight fasting window. For active individuals eating across a 14–16 hour window with multiple feeding occasions, compressing the eating window to 8–10 hours without reducing food quality produces significant improvements in fasting insulin over 8–12 weeks. The training session does not need to be fueled by pre-workout nutrition in most recreational athletes — this is a sports nutrition industry construct, not a physiological requirement for training sessions under 90 minutes at moderate intensity.

Prioritize protein from whole food sources. The protein bar and shake culture in the fitness world frequently delivers protein alongside the ultra-processed ingredients described above. Replacing these with whole food protein sources — meat, eggs, fish, dairy — addresses both the protein adequacy and the gut-barrier disruption simultaneously.

Measure fasting insulin before and after. The active individual who implements these changes and tracks fasting insulin at baseline and at 8–12 weeks will see a measurable downward shift that no performance metric would have captured. That number — moving from 14 to 7 µIU/mL, for example — is the confirmation that the metabolic environment has shifted in the direction that training alone was unable to produce.

A Note on Uncertainty

The mechanisms described here — gut-derived LPS translocation, TLR4-mediated hepatic inflammation, and circadian insulin dysregulation from evening training — are well-supported in the research literature. Their specific contribution in any given active individual relative to other drivers is harder to quantify and varies substantially between people.

Not every active individual consuming sports nutrition products will develop insulin resistance through the gut-liver axis mechanism. Metabolic resilience varies. Genetic factors, baseline gut microbiome composition, training volume, sleep quality, and overall dietary pattern all influence susceptibility. The argument here is not that fitness is metabolically irrelevant — it is a powerful protective factor. The argument is that it is not sufficient on its own to guarantee metabolic health when the dietary and lifestyle environment is generating upstream drivers that exercise cannot neutralize.

Next Steps

If you are regularly active, maintain a reasonable body weight, and have been told your standard labs look fine — but you experience energy crashes after meals, persistent fatigue, cravings that your training does not resolve, or a waist circumference that will not move despite consistent exercise — request a fasting insulin test at your next blood draw. Ask specifically. It will not be on the standard panel.

That number, interpreted against a functional threshold rather than a laboratory reference range, will tell you more about your actual metabolic trajectory than any fitness metric you are currently tracking.

Being fit is not the same as being metabolically healthy. The gap between the two is measurable — and it is found not in the gym but in the lab.

People Also Ask

Can athletes have insulin resistance?

Yes. Regular exercise improves peripheral insulin sensitivity through GLUT4-mediated glucose disposal and mitochondrial enhancement. But exercise does not neutralize gut-liver axis disruption from ultra-processed sports nutrition products, chronic sleep impairment from evening training, or the hormonal consequences of sustained cortisol elevation. Active individuals can have hidden insulin resistance that standard screening — and standard clinical assumptions about fit people — consistently misses.

What causes insulin resistance in active people?

The most consistently underestimated driver in active individuals is gut-liver axis disruption caused by ultra-processed sports nutrition products — protein bars, gym drinks, and recovery snacks containing industrial seed oils, HFCS, emulsifiers, and refined carbohydrates. These products cause microbiome dysbiosis and increased intestinal permeability, allowing LPS from gram-negative bacteria to enter the portal circulation and trigger hepatic insulin resistance through TLR4-mediated inflammation.

Can you be fit and still have high insulin?

Yes — and this is the central clinical point of this post. Fasting insulin reflects the hormonal environment across all tissues, not just skeletal muscle insulin sensitivity. An individual with excellent muscular glucose disposal capacity can simultaneously have hepatic insulin resistance driven by gut-liver axis disruption, elevated fasting insulin from compensatory pancreatic secretion, and a standard blood panel that shows nothing abnormal.

Does exercise lower insulin resistance?

Exercise — particularly resistance training and HIIT — significantly improves peripheral insulin sensitivity and lowers fasting insulin over time. However, these benefits are conditional on a dietary and lifestyle environment that does not simultaneously generate the upstream drivers that exercise is partially offsetting. Exercise combined with gut-barrier-disrupting ultra-processed products, poor sleep from late training, and frequent eating across a wide window produces a net metabolic outcome that is substantially worse than the training alone would suggest.

What should active people eat to avoid insulin resistance?

The priority for active individuals is elimination of ultra-processed sports nutrition products — replacing protein bars, gym drinks, and refined carbohydrate snacks with whole food protein sources including meat, eggs, fish, and dairy. Compressing the eating window to 8–10 hours, timing training earlier in the day where possible, and prioritizing sleep quality addresses the three primary drivers of hidden insulin resistance in active individuals simultaneously.

About the Author

Morteza Ariana is a State-Certified Functional Nutritionist based in Germany, specializing in insulin resistance, type 2 diabetes, and root-cause metabolic restoration. He holds advanced training in systems-based physiology and has worked with patients across the U.S. and Europe for over 10 years.

His clinical framework is built around a core principle that mainstream medicine consistently overlooks: chronically elevated insulin — not blood glucose — is the earliest and most actionable driver of metabolic disease. That conviction was shaped in part by his own experience with hyperinsulinemia in 2016, and deepened through a decade of clinical practice and the study of leading researchers in metabolic medicine including Benjamin Bikman, Joseph Kraft, Gerald Reaven, Jason Fung, and Stephen Phinney.

His work focuses on identifying and correcting the upstream metabolic signals — insulin load, liver-gut axis dysfunction, circadian misalignment, and micronutrient gaps — that standard screening misses entirely. Patient outcomes are documented, anonymized, and published on this site.

Read the full bio →

If this resonates, the next step is clarity

The Metabolic Restoration Blueprint is a structured 12-week framework designed to correct upstream metabolic drivers — not just manage symptoms.

Explore the Metabolic Restoration Blueprint

The Animal-Based Protocol for Insulin Resistance →

Key References

  1. Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiological Reviews. 2018;98(4):2133–2223.
  2. Cani PD, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772.
  3. Hawley JA, Lessard SJ. Exercise training-induced improvements in insulin action. Acta Physiologica. 2008;192(1):127–135.
  4. Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64.
  5. Chassaing B, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92–96.
  6. Van Cauter E, et al. Sleep and the epidemic of obesity in children and adults. European Journal of Endocrinology. 2008;159(Suppl 1):S59–S66.
  7. Sutton EF, et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metabolism. 2018;27(6):1212–1221.
  8. Bikman BT. A role for sphingolipids in producing the common entities of obesity-associated insulin resistance. Cell Biochemistry and Function. 2012;30(7):540–546.
  9. Youm YH, et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature Medicine. 2015;21(3):263–269.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top